Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vyome Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10608
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are used for antimicrobial resistance development. Vyome develops Dual Action Rational Therapeutics platform and Molecular Replacement Therapeutics platform. The company’s anti-fungal platform technology is used for the treatment of recalcitrant fungal infections. It also develops treatment options for tinea and candida fungi species, skin fungal infection, acne and seborrheic dermatitis. The company has operations in Delhi and Gujarat, India. Vyome is headquartered in New Delhi, Delhi, India.

Vyome Biosciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vyome Biosciences Raises USD14 Million in Series C Financing 10
Vyome Biosciences Raises USD8 Million in Series B Venture Financing 11
Vyome Biosciences Raises US$3 Million In Series A Financing 12
Licensing Agreements 13
Vyome Biosciences Enters into Licensing Agreement for Dermatology Products 13
Vyome Biosciences Pvt Ltd – Key Competitors 14
Vyome Biosciences Pvt Ltd – Key Employees 15
Vyome Biosciences Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Clinical Trials 17
Apr 24, 2017: Vyome Completes Enrollment for Proof of Concept Clinical Study of VB 1953 17
Feb 07, 2017: Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vyome Biosciences Raises USD14 Million in Series C Financing 10
Vyome Biosciences Raises USD8 Million in Series B Venture Financing 11
Vyome Biosciences Raises US$3 Million In Series A Financing 12
Vyome Biosciences Enters into Licensing Agreement for Dermatology Products 13
Vyome Biosciences Pvt Ltd, Key Competitors 14
Vyome Biosciences Pvt Ltd, Key Employees 15
Vyome Biosciences Pvt Ltd, Other Locations 16

List of Figures
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Solartron Public Company Limited (SOLAR):企業の財務・戦略的SWOT分析
    Solartron Public Company Limited (SOLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Intershop Communications AG (ISH2):企業の財務・戦略的SWOT分析
    Summary Intershop Communications AG (Intershop), formerly NetConsult GmbH, is an information technology company that develops and offers integrated e-commerce solutions. The company provides services such as omni-channel management, experience management, product information management, marketing an …
  • Northern Oil & Gas Inc (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • China Merchants Securities Co Ltd (600999):企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • CoreLogic Inc (CLGX):企業の財務・戦略的SWOT分析
    CoreLogic Inc (CLGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Steelcase Inc. (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc. (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Risk Strategies Company Inc:企業のM&A・事業提携・投資動向
    Risk Strategies Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Risk Strategies Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Dubai Electricity and Water Authority:電力:M&Aディール及び事業提携情報
    Summary Dubai Electricity and Water Authority (DEWA) is an electricity and water utility. It generates, transmits and distributes electricity; and desalinates water. The authority produces electricity using gas and steam turbines, and solar PV plants. DEWA’s plants include Jebel Ali Station D, E and …
  • Boursorama SA:企業の戦略・SWOT・財務情報
    Boursorama SA - Strategy, SWOT and Corporate Finance Report Summary Boursorama SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) is a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purification, a …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • McRae Industries, Inc.:企業の戦略・SWOT・財務情報
    McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Instrumentation Laboratory Company:企業の製品パイプライン分析2018
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • Doosan Fuel Cell America Inc:電力:M&Aディール及び事業提携情報
    Summary Doosan Fuel Cell America Inc (Doosan Fuel Cell), formerly Quantum Leap Technology Inc, a subsidiary of Doosan Corp, is a energy solution provider that manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment service, financi …
  • Lumenis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Lumenis Ltd (Lumenis), a subsidiary of XIO Group, is an energy-based medical device company for aesthetic, surgical and ophthalmic applications in the field of minimally invasive clinical solutions. It manufactures and distributes medical and aesthetic lasers and light-based systems. Its maj …
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務情報
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Sasol Ltd (SOL):企業の財務・戦略的SWOT分析
    Sasol Ltd (SOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bourbon Corporation:企業の戦略・SWOT・財務情報
    Bourbon Corporation - Strategy, SWOT and Corporate Finance Report Summary Bourbon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆